Biofrontera regains Nasdaq compliance on stockholders' equity rule; future warning

Biofrontera Inc.

May 17, 2024 Nasdaq notice confirms compliance with Rule 5550(b)(1) based on Q1 2024 10-Q.
Prior non-compliance disclosed Nov 2023 due to stockholders' equity deficiency in Q3 2023.
Notice cautions that failure to maintain compliance in next periodic report may result in delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.